These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 18613897

  • 1. Cardiovascular testing in Fabry disease: exercise capacity reduction, chronotropic incompetence and improved anaerobic threshold after enzyme replacement.
    Lobo T, Morgan J, Bjorksten A, Nicholls K, Grigg L, Centra E, Becker G.
    Intern Med J; 2008 Jun; 38(6):407-14. PubMed ID: 18613897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Cardiopulmonary exercise capacity increases after interventional ASD-closure].
    Weber M, Neumann T, Rau M, Brandt R, Dill T, Maikowski C, Mitrovic V, Hamm C.
    Z Kardiol; 2004 Mar; 93(3):209-15. PubMed ID: 15024588
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation between CD34+ and exercise capacity, functional class, quality of life and norepinephrine in heart failure patients.
    Carvalho VO, Ruiz MA, Bocchi EA, Carvalho VO, Guimarães GV.
    Cardiol J; 2009 Mar; 16(5):426-31. PubMed ID: 19753521
    [Abstract] [Full Text] [Related]

  • 7. Six-minute walk test and cardiopulmonary exercise testing in patients with chronic heart failure: a comparative analysis on clinical and prognostic insights.
    Guazzi M, Dickstein K, Vicenzi M, Arena R.
    Circ Heart Fail; 2009 Nov; 2(6):549-55. PubMed ID: 19919979
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa.
    Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, Mehta AB.
    Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cardiological follow-up in patients with Fabry disease].
    Pieruzzi F, Pieroni M, Chimenti C, Frustaci A, Sarais C, Cecchi F, Area Cardiologica-Advisory Board Plan Multidisciplinare "Diagnosi e Follow-up Malattia di Fabry".
    G Ital Cardiol (Rome); 2010 Feb; 11(7-8):566-72. PubMed ID: 21033333
    [Abstract] [Full Text] [Related]

  • 15. The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction.
    Passman R, Banthia S, Galvez D, Sheldon T, Kadish A.
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):1-6. PubMed ID: 19140906
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Importance of heart rate during exercise for response to cardiac resynchronization therapy.
    Maass AH, Buck S, Nieuwland W, Brügemann J, van Veldhuisen DJ, Van Gelder IC.
    J Cardiovasc Electrophysiol; 2009 Jul; 20(7):773-80. PubMed ID: 19207785
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.